Febit to Debut HybSelector Instrument, Disease-Specific Sequence Capture Arrays in 2010 | GenomeWeb

By Justin Petrone

Febit next year plans to expand its menu of products for customers that use its sequence-capture arrays with second-generation sequencers.

Chief Scientific Officer Peer Stähler told BioArray News this week that the Heidelberg, Germany-based firm will launch a new instrument called HybSelector designed specifically for processing the firm's HybSelect sequence-capture arrays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.